title: [Translational research and Cancer Plan].
abstract: The French Cancer Plan 2003-2007 has made translational research central to its research programme, to ensure the care-research continuum and the quickest application possible for the most recent discoveries, for the patients' benefit. This is a new field of research, still little-known or ill-understood. A working group, composed of physicians and researchers from academic research and industrial research, sought to define translational research in cancerology and define the issues at stake in it. Translational research needs to develop in close connection with the patients in order to enable a bi-directional flow of knowledge from cognitive research toward medical applications and from observations made on patients toward cognitive research. Placed under the aegis of the French National Cancer Institute and Leem Research, the group has put forth a strategy for implementing translational research in cancerology in France to make it attractive, competitive and efficient and to foster the development of public-private partnerships.
authors.affiliation: Cancéropôle Ile-de-France, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75475 Paris Cedex 10, France. gilles.vassal@igr.fr
authors.forename: G
authors.initials: G
authors.lastname: Vassal
authors.forename: L
authors.initials: L
authors.lastname: Borella
authors.forename: A
authors.initials: A
authors.lastname: Pierre
authors.forename: R
authors.initials: R
authors.lastname: Pamphile
authors.forename: B
authors.initials: B
authors.lastname: Bourrie
authors.forename: K
authors.initials: K
authors.lastname: Meflah
authors.forename: F
authors.initials: F
authors.lastname: Amalric
authors.forename: I
authors.initials: I
authors.lastname: Pauporte
authors.forename: J-L
authors.initials: JL
authors.lastname: Caillot
authors.forename: P
authors.initials: P
authors.lastname: Formstecher
authors.forename: B
authors.initials: B
authors.lastname: Demers
authors.forename: C
authors.initials: C
authors.lastname: Dumontet
authors.forename: M
authors.initials: M
authors.lastname: Grégoire
authors.forename: F
authors.initials: F
authors.lastname: Lethiec
authors.forename: A-M
authors.initials: AM
authors.lastname: Boue
authors.forename: D
authors.initials: D
authors.lastname: Tonelli
authors.forename: R
authors.initials: R
authors.lastname: Pilsudski
authors.forename: L
authors.initials: L
authors.lastname: Van Hijfte
authors.forename: C
authors.initials: C
authors.lastname: Cailliot
authors.forename: P
authors.initials: P
authors.lastname: Vrignaud
authors.forename: J-L
authors.initials: JL
authors.lastname: Merlin
authors.forename: P
authors.initials: P
authors.lastname: Oudet
authors.forename: P-Y
authors.initials: PY
authors.lastname: Arnoux
authors.forename: C
authors.initials: C
authors.lastname: Lassale
mesh_terms: D035843:Biomedical Research / Q000458:organization & administration* / Q000592:standards; D004059:Diffusion of Innovation; D005602:France; D006801:Humans; D033183:Interdisciplinary Communication; D023421:Models, Animal; D009369:Neoplasms / Q000235:genetics / Q000628:therapy*; D010358:Patient Participation / Q000379:methods
vernacular_title: Recherche translationnelle et plan Cancer.